[go: up one dir, main page]

DE69823981D1 - Verwendung von Peptidverbindungen zur Behandlung von SLE - Google Patents

Verwendung von Peptidverbindungen zur Behandlung von SLE

Info

Publication number
DE69823981D1
DE69823981D1 DE69823981T DE69823981T DE69823981D1 DE 69823981 D1 DE69823981 D1 DE 69823981D1 DE 69823981 T DE69823981 T DE 69823981T DE 69823981 T DE69823981 T DE 69823981T DE 69823981 D1 DE69823981 D1 DE 69823981D1
Authority
DE
Germany
Prior art keywords
treatment
sle
peptide compounds
thr
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69823981T
Other languages
English (en)
Other versions
DE69823981T2 (de
Inventor
Maria Marino
Maria Rossi
Giorgio Fassina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tecnogen SpA
Original Assignee
Tecnogen SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnogen SpA filed Critical Tecnogen SpA
Publication of DE69823981D1 publication Critical patent/DE69823981D1/de
Application granted granted Critical
Publication of DE69823981T2 publication Critical patent/DE69823981T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69823981T 1998-05-21 1998-05-21 Verwendung von Peptidverbindungen zur Behandlung von SLE Expired - Fee Related DE69823981T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98830310A EP0958829B1 (de) 1998-05-21 1998-05-21 Verwendung von Peptidverbindungen zur Behandlung von SLE

Publications (2)

Publication Number Publication Date
DE69823981D1 true DE69823981D1 (de) 2004-06-24
DE69823981T2 DE69823981T2 (de) 2005-05-25

Family

ID=8236657

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69823981T Expired - Fee Related DE69823981T2 (de) 1998-05-21 1998-05-21 Verwendung von Peptidverbindungen zur Behandlung von SLE

Country Status (7)

Country Link
US (1) US6303577B1 (de)
EP (1) EP0958829B1 (de)
JP (1) JP2000053580A (de)
AT (1) ATE267018T1 (de)
CA (1) CA2270687A1 (de)
DE (1) DE69823981T2 (de)
ES (1) ES2218796T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
DK2319928T3 (da) 1998-10-23 2013-06-24 Kirin Amgen Inc Dimere trombopoietiske peptidomimetika, der binder til MPL-receptor og har trombopoietisk aktivitet
US6916904B2 (en) 2002-04-24 2005-07-12 Zolaris Biosciences, Llc Inhibition of immune complex formation
CN101103045B (zh) 2004-09-24 2015-11-25 安姆根有限公司 修饰的Fc分子
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
TW200827367A (en) 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome
US20170044591A1 (en) * 2014-04-24 2017-02-16 Alnylam Pharmaceuticals, Inc. Methods and compositions for detecting anti-drug antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016410A1 (en) * 1995-10-30 1997-05-09 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins

Also Published As

Publication number Publication date
ES2218796T3 (es) 2004-11-16
EP0958829A1 (de) 1999-11-24
CA2270687A1 (en) 1999-11-21
DE69823981T2 (de) 2005-05-25
JP2000053580A (ja) 2000-02-22
US6303577B1 (en) 2001-10-16
EP0958829B1 (de) 2004-05-19
ATE267018T1 (de) 2004-06-15

Similar Documents

Publication Publication Date Title
ATE253063T1 (de) 5-ht1f-agonisten
DK0572166T3 (da) Hidtil ukendte 7beta-substitueret-4-aza-5beta-androstan-3-oner som 5beta-reduktaseinhibitorer
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
TR199901653T2 (xx) Fitalazinonlar.
NO944406D0 (no) Nye 7 se inhibitorer
DE60227718D1 (de) Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
IL133279A0 (en) Carboxamides useful as 5-ht1f agonists
DE3486438D1 (de) Verfahren zur Herstellung von 1-(Phenyl)-1-hydroxy-2-amino-3-fluor-propan-Derivaten
DE69823981D1 (de) Verwendung von Peptidverbindungen zur Behandlung von SLE
TR199901386T2 (en) �midazopiridazinler.
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
DE69940971D1 (de) Verwendung von erythropoietin zur behandlung von primärer hämochromatosen
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
BR9902096A (pt) Pitazóis.
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
EP0457723A3 (de) Verfahren zum Stabilisieren von Magentakupplern und den entsprechenden Bildfarbstoffen in photographischen Materialien
DE59904904D1 (de) Verfahren zur Herstellung von Phenyldichloro-1,3,5-triazinverbindungen
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ES2053808T3 (es) Nuevos compuestos azolicos.
DE69807990D1 (de) Verfahren zur Stabilisierung von 4,6-Diaminoresorcin und dessen Salzen
MY126408A (en) Insecticidal oxadiazine compounds
ID27964A (id) Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
ATE137973T1 (de) Phospholipide zur behandlung der multiplen sklerose
EE04369B1 (et) Alfa-arüülalkaanhapete valmistamismeetod

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee